Profile data is unavailable for this security.
About the company
Standard BioTools Inc. develops, manufactures and sells a diversified range of instrumentation, consumables, and services that help scientists and biomedical researchers. The Company's segments include Proteomics and Genomics. The Proteomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of proteins. The Genomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of genes (DNA, RNA) and their functions. The Company works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy. It offers a diverse range of instrumentation, consumables, and services that generate data across early discovery, translational and clinical research.
- Revenue in USD (TTM)128.83m
- Net income in USD-109.46m
- Incorporated2007
- Employees818.00
- LocationStandard BioTools Inc50 MILK STREET, 10TH FLOORBOSTON 02109United StatesUSA
- Phone+1 (650) 266-6000
- Fax+1 (302) 655-5049
- Websitehttps://www.standardbio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Clearpoint Neuro Inc | 34.33m | -23.14m | 400.41m | 115.00 | -- | 24.11 | -- | 11.66 | -0.8264 | -0.8264 | 1.23 | 0.5584 | 0.6829 | 1.95 | 7.52 | 298,539.10 | -46.03 | -35.94 | -54.48 | -41.48 | 61.31 | 63.49 | -67.40 | -74.87 | 5.56 | -92.37 | 0.6479 | -- | 31.04 | 22.85 | 14.37 | -- | 11.41 | -- |
| Orthopediatrics Corp | 227.41m | -45.61m | 417.54m | 562.00 | -- | 1.20 | -- | 1.84 | -1.96 | -1.96 | 9.74 | 13.93 | 0.4628 | 0.5149 | 4.83 | 404,644.10 | -9.28 | -5.87 | -9.97 | -6.44 | 71.73 | 74.27 | -20.06 | -16.55 | 3.52 | -5.96 | 0.2214 | -- | 37.65 | 23.06 | -80.33 | -- | 4.29 | -- |
| Cerus Corp | 225.97m | -15.96m | 422.59m | 281.00 | -- | 6.87 | -- | 1.87 | -0.0848 | -0.0848 | 1.20 | 0.3201 | 1.12 | 1.99 | 8.35 | 804,163.70 | -7.91 | -20.38 | -12.30 | -31.96 | 60.50 | 61.15 | -7.09 | -25.37 | 1.29 | -1.04 | 0.5772 | -- | 7.78 | 16.51 | 44.20 | -- | -20.50 | -- |
| AngioDynamics, Inc. | 307.31m | -27.71m | 435.26m | 675.00 | -- | 2.49 | -- | 1.42 | -0.6731 | -0.6731 | 7.47 | 4.24 | 1.10 | 2.12 | 7.02 | 455,268.20 | -9.87 | -13.69 | -13.83 | -16.19 | 54.58 | 52.46 | -9.02 | -21.32 | 1.33 | -- | 0.0329 | -- | -3.76 | 2.06 | 81.56 | -- | -10.06 | -- |
| Myriad Genetics Inc | 825.30m | -400.50m | 477.25m | 2.70k | -- | 1.28 | -- | 0.5783 | -4.34 | -4.34 | 8.97 | 4.00 | 0.9122 | 8.46 | 6.77 | 305,666.70 | -44.27 | -- | -53.15 | -- | 70.36 | -- | -48.53 | -- | 2.12 | -14.93 | 0.2427 | -- | 11.21 | -- | 51.65 | -- | -- | -- |
| Standard Biotools Inc | 128.83m | -109.46m | 484.55m | 818.00 | -- | 1.21 | -- | 3.76 | -0.289 | -0.3383 | 0.3399 | 1.04 | 0.211 | 1.97 | 5.27 | 157,490.20 | -17.93 | -29.45 | -22.06 | -35.68 | 47.94 | 50.11 | -84.97 | -79.68 | 4.14 | -- | 0.0008 | -- | 64.03 | 8.27 | -147.67 | -- | 26.98 | -- |
| Anteris Technologies Global Corp | 2.14m | -84.32m | 503.51m | 136.00 | -- | 53.54 | -- | 235.38 | -2.34 | -2.34 | 0.0594 | 0.1025 | 0.1065 | 1.53 | 11.88 | 15,728.75 | -420.16 | -- | -1,527.00 | -- | 67.94 | -- | -3,945.70 | -- | 0.8032 | -- | 0.046 | -- | -1.16 | -- | -65.77 | -- | -- | -- |
| Orthofix Medical Inc | 818.06m | -119.12m | 506.88m | 1.62k | -- | 1.14 | -- | 0.6196 | -3.04 | -3.04 | 20.82 | 11.20 | 0.9622 | 1.37 | 6.40 | 506,224.00 | -14.01 | -10.81 | -17.28 | -13.34 | 68.27 | 70.31 | -14.56 | -11.57 | 1.38 | -1.35 | 0.2837 | -- | 7.08 | 11.69 | 16.78 | -- | 8.75 | -- |
| Mesa Laboratories Inc | 247.54m | 3.73m | 515.30m | 730.00 | 144.14 | 2.76 | 17.92 | 2.08 | 0.6471 | 0.6471 | 44.81 | 33.79 | 0.5678 | 3.40 | 6.28 | 339,097.30 | 0.8564 | -8.81 | 1.13 | -9.71 | 62.40 | 61.98 | 1.51 | -25.15 | 1.45 | 1.62 | 0.4709 | -- | 11.47 | 15.41 | 99.22 | -- | 24.60 | 0.00 |
| Neuropace Inc | 94.86m | -23.99m | 518.39m | 209.00 | -- | 28.16 | -- | 5.46 | -0.7535 | -0.7535 | 2.98 | 0.5564 | 0.9321 | 1.46 | 7.16 | 515,565.20 | -23.57 | -35.71 | -28.36 | -44.34 | 76.77 | 73.39 | -25.28 | -60.45 | 3.94 | -3.58 | 0.7603 | -- | 22.14 | 16.67 | 17.64 | -- | -8.15 | -- |
| Pacific Biosciences of California Inc | 154.58m | -503.63m | 549.47m | 575.00 | -- | 15.22 | -- | 3.55 | -1.69 | -1.69 | 0.5236 | 0.1196 | 0.1372 | 1.80 | 5.15 | 268,841.80 | -44.70 | -16.31 | -47.29 | -17.71 | 30.95 | 34.48 | -325.80 | -156.40 | 5.40 | -19.94 | 0.947 | -- | -23.19 | 11.12 | -1.02 | -- | 16.89 | -- |
| Cytek Biosciences Inc | 196.83m | -12.82m | 571.56m | 692.00 | -- | 1.51 | -- | 2.90 | -0.1011 | -0.1011 | 1.54 | 2.96 | 0.3992 | 1.86 | 3.60 | 303,746.90 | -2.60 | 0.3407 | -3.02 | 0.3811 | 53.46 | 58.12 | -6.51 | 0.8678 | 4.48 | -- | 0.0213 | -- | 3.85 | 28.20 | 50.44 | -- | 30.83 | -- |
| Beta Bionics Inc | 88.57m | -77.84m | 575.84m | 404.00 | -- | 1.95 | -- | 6.50 | -2.07 | -2.07 | 2.21 | 6.70 | 0.4149 | 2.54 | 8.16 | 304,364.30 | -36.46 | -- | -40.57 | -- | 54.51 | -- | -87.89 | -- | 9.83 | -- | 0.00 | -- | 442.93 | -- | -24.17 | -- | -- | -- |
| Varex Imaging Corp | 844.60m | -70.30m | 586.87m | 2.40k | -- | 1.23 | -- | 0.6949 | -1.70 | -1.70 | 19.25 | 11.34 | 0.7267 | 1.96 | 5.37 | 351,916.70 | -6.01 | -0.3327 | -7.31 | -0.3955 | 34.39 | 33.16 | -8.28 | -0.4661 | 1.83 | 2.45 | 0.4343 | -- | 4.14 | 2.73 | -47.38 | -- | -0.5159 | -- |
Data as of Feb 06 2026. Currency figures normalised to Standard BioTools Inc's reporting currency: US Dollar USD
62.65%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Casdin Capital LLCas of 04 Dec 2025 | 88.78m | 23.09% |
| Viking Global Investors LPas of 30 Sep 2025 | 58.65m | 15.25% |
| BlackRock Fund Advisorsas of 30 Sep 2025 | 21.81m | 5.67% |
| MAK Capital One LLCas of 31 Dec 2025 | 19.97m | 5.19% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 15.06m | 3.92% |
| Long Focus Capital Management LLCas of 30 Sep 2025 | 11.36m | 2.96% |
| Geode Capital Management LLCas of 30 Sep 2025 | 7.47m | 1.94% |
| SSgA Funds Management, Inc.as of 30 Sep 2025 | 6.40m | 1.67% |
| Hollow Brook Wealth Management LLCas of 30 Sep 2025 | 5.78m | 1.50% |
| Morgan Stanley Investment Management, Inc.as of 30 Sep 2025 | 5.64m | 1.47% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
